Goto et al. showed that TLR2, TLR3, and TLR4 are highly expressed in human melanoma cells and that downstream signal transduction factors, such as NF-κB, and inflammatory response-related factors are activated in these cells (67). The gene discussed is TLR3; the disease is melanoma.